Peter Diamandis - 10 Nov 2021 Form 3/A - Amendment Insider Report for Vaxxinity, Inc.

Role
Director
Signature
/s/ Rene Paula Molina, attorney-in-fact for Peter Diamandis
Issuer symbol
VAXX on OTC
Transactions as of
10 Nov 2021
Net transactions value
$0
Form type
3/A - Amendment
Filing time
23 Jun 2022, 19:42:25 UTC
Date Of Original Report
10 Nov 2021
Previous filing
13 Sep 2021
Next filing
23 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VAXX Series A preferred stock 10 Nov 2021 Class A common stock 13,824 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person unintentionally omitted this holding from the Form 3 filed on November 10, 2021.
F2 The 21,511 shares of Series A preferred stock will convert into 13,824 shares of Class A common stock automatically upon closing of the initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of Series A preferred stock.